Evolution Winning in Bacteria vs Antibiotics Arms Race

Science is running out of new ways to attack harmful bacteria, while drug companies are abandoning antibiotic research and development, according to a University of Adelaide drug expert.

Written byUniversity of Adelaide
| 2 min read
Register for free to listen to this article
Listen with Speechify
0:00
2:00

Science is running out of new ways to attack harmful bacteria, while drug companies are abandoning antibiotic research and development, according to a University of Adelaide drug expert.

Speaking during Antibiotic Awareness Week (18-24 November), Dr. Ian Musgrave from the University's School of Medical Sciences says whenever a new antibiotic is developed, harmful bacteria evolve to become resistant within a relatively short period of time.

"There's no doubt that evolution is winning the antibiotics arms race," says Dr. Musgrave, a Senior Lecturer in Pharmacology.

To continue reading this article, sign up for FREE to
Lab Manager Logo
Membership is FREE and provides you with instant access to eNewsletters, digital publications, article archives, and more.
Add Lab Manager as a preferred source on Google

Add Lab Manager as a preferred Google source to see more of our trusted coverage.

Related Topics

Current Magazine Issue Background Image

CURRENT ISSUE - April 2026

When Lab Innovation Meets Sustainability

Why Performance, Cost, and Environmental Impact Now Compete in Procurement

Lab Manager April 2026 Cover Image